THE VOICE OF ONCOLOGY IN FLORIDA FLASCO is a member supported state society that focuses on providing education, advocacy, communication and general support of the Florida professionals who have chosen the challenging medical discipline of oncology. UPCOMING EVENTS CORPORATE MEMBERSHIP BENEFITS BENEFITS FOR ONCOLOGY PROFESSIONALS FLASCO

Latest News & Updates

FDA grants accelerated approval to pembrolizumab for HER2-positive gastric cancer
May 6, 2021

Continue Reading »

FDA grants accelerated approval to dostarlimab-gxly for dMMR endometrial cancer
April 26, 2021

Continue Reading »

FDA grants accelerated approval to loncastuximab tesirine-lpyl for large B-cell lymphoma
April 26, 2021

Continue Reading »

FDA approves nivolumab in combination with chemotherapy for metastatic gastric cancer and esophageal adenocarcinoma
April 16, 2021

Continue Reading »

FDA grants accelerated approval to pembrolizumab for HER2-positive gastric cancer
May 6, 2021

Continue Reading »

FDA Approves Immunotherapy for Endometrial Cancer with Specific Biomarker
April 29, 2021

Continue Reading »

FDA grants accelerated approval to dostarlimab-gxly for dMMR endometrial cancer
April 26, 2021

Continue Reading »

FDA grants accelerated approval to loncastuximab tesirine-lpyl for large B-cell lymphoma
April 26, 2021

Continue Reading »

Get More from FLASCO With Your Membership

The Corporate Membership Program allows FLASCO to expand our offerings to our membership. Every FLASCO meeting also provides the industry representative with opportunities to educate our members. When you send representatives to a FLASCO meeting, you are allowing them to share their knowledge, as well as receive the same knowledge as our members by participating within the educational sessions. This helps ensure that the hematology and oncology community at large are learning, sharing best practices, and finding solutions to problems together.

Corporate Members:

We're Here to Help Contact Us

Contact Us

Add your name, email & message below: